Vertex Pharmaceuticals
VRTX
VRTX
1,595 hedge funds and large institutions have $115B invested in Vertex Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 209 funds opening new positions, 632 increasing their positions, 569 reducing their positions, and 126 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,595
Holders Change
+54
Holders Change %
+3.5%
% of All Funds
21.66%
Holding in Top 10
26
Holding in Top 10 Change
+10
Holding in Top 10 Change %
+62.5%
% of All Funds
0.35%
New
209
Increased
632
Reduced
569
Closed
126
Calls
$771M
Puts
$596M
Net Calls
+$175M
Net Calls Change
+$95M
Top Buyers
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
+$1.99B |
| 2 |
JPMorgan Chase & Co
New York
|
+$699M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$595M |
| 4 |
Jennison Associates
New York
|
+$361M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$216M |
